Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia

British Journal of Ophthalmology

Volumn 95, Issue 7, 2011, Pages 947-950

  Rudkin, Adam K ^a   Muecke, James S ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA DISEASE; CRYOTHERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECTROPION; EPIPHORA; EYE CANCER; EYELID DISEASE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATITIS; MAJOR CLINICAL STUDY; MALE; OCULAR SURFACE SQUAMOUS NEOPLASIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT CANCER;

AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; EYE NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SQUAMOUS CELL; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VISION, OCULAR;

EID: 79959367021     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.186171     Document Type: Article

References (27)

1. Heigle TJ, Stulting RD, Palay DA. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 1997;124:397-9. (Pubitemid 27383107)
2. Chen C, Louis D, Dodd T, et al. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol 2004;88:17-18. (Pubitemid 38091352)
3. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctivalecorneal intraepithelial neoplasia: a multicenter experience. Ophthalmol 1997;104:2085-93. (Pubitemid 28053436)
4. Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 2002;133:601-6. (Pubitemid 34462006)
5. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 1997;124:303-11. (Pubitemid 27383095)
6. Gupta A, Muecke J. Treatment of ocular surface squamous neoplasia with mitomycin C. Br J Ophthalmol 2010;94:555-8.
7. de Keizer RJ, de Wolff-Rouendaal D, van Delft JL. Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid. Doc Ophthalmol 1986;64:31-42.
8. Yeatts RP, Ford JG, Stanton CA, et al. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Ophthalmol 1995;102:1338-44.
9. Yeatts RP, Engelbrecht NE, Curry CD, et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmol 2000;107:2190-5.
10. Yamamoto N, Ohmura T, Suzuki H, et al. Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C. Ophthalmol 2002;109:249-52. (Pubitemid 34106025)
11. Midena E, Angeli CD, Valenti M, et al. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol 2000;84:268-72. (Pubitemid 30251681)
12. Midena E, Boccato P, Angeli CD. Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil. Arch Ophthalmol 1997;115:1600-1. (Pubitemid 28007151)
13. Boehm MD, Huang AJW. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Ophthalmol 2004;111:1755-61. (Pubitemid 39179693)
14. Karp CL, Moore JK, Rosa RH. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmol 2001;108:1093-8. (Pubitemid 32500027)
15. Maskin SL. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol 1994;112:1145-6. (Pubitemid 24360950)
16. Tunc M, Char DH, Crawford B, et al. Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. Br J Ophthalmol 1999;83:98-103. (Pubitemid 29106341)
17. Peksayar G, Soytürk MK, Demiryont M. Long-term results of cryotherapy on malignant epithelial tumors of the conjunctiva. Am J Ophthalmol 1989;107:337-40. (Pubitemid 19100923)
18. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol 1995;39:429-50.
19. Erie JC, Campbell RJ, Liesegang TJ. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmol 1986;93:176-83. (Pubitemid 16079555)
20. Lee GA, Hirst LW. Retrospective study of ocular surface squamous neoplasia. Aust N Z J Ophthalmol 1997;25:269-76. (Pubitemid 27501774)
21. Tabin G, Levin S, Snibson G, et al. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmol 1997;104:485-92. (Pubitemid 27120305)
22. Sudesh S, Rapuano CJ, Cohen EJ, et al. Surgical management of ocular surface squamous neoplasms: the experience from a cornea center. Cornea 2000;19:278-83. (Pubitemid 30322448)
23. Char DH, Crawford JB. Orbital invasion despite topical anti-metabolite therapy for conjunctival carcinoma. Graefes Arch Clin Exp Ophthalmol 2008;246:459-61.
24. Abraham LM, Selva D, Casson R, et al. The clinical applications of fluorouracil in ophthalmic practice. Drugs 2007;67:237-55.
25. Knapp A, Heuer DK, Stern GA, et al. Serious corneal complications of glaucoma filtering surgery with postoperative 5-fluorouracil. Am J Ophthalmol 1987;103:183-7. (Pubitemid 17005482)
26. Parrozzani R, Lazzarini D, Alemany-Rubio E, et al. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study. Br J Ophthalmol 2011;95:355-9.
27. Sepulveda R, Pe'er J, Midena E, et al. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmol 2010;94:532-5.